Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  1998-10-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0960-894X(98)00504-6PMID 9873625
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist.

  1998cited by this paper
• Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.

  1998cited by this paper
• Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.

  1998cited by this paper
• Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.

  1998cited by this paper
• Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.

  1996cited by this paper
• Synthesis and biology of the rigidified glutamate analogue, trans-2-carboxyazetidine-3-acetic acid (t-CAA)

  1996cited by this paper
• Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-ones.

  1995cited by this paper
• Rome "could host European mouse laboratory"

  1994cited by this paper
• Regioselective metalation reactions of some substituted (methoxymethoxy)arenes

  1982cited by this paper

• Light‐Activated Pharmacological Tools for Exploring the Cholinergic System

  2025cites this paper
• Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography

  2023cites this paper
• Azetidines of pharmacological interest

  2021cites this paper
• Design, Synthesis, In Silico Studies and In Vitro Anticancer Activity of 3‐(4‐Methoxyphenyl)azetidine Derivatives

  2020cites this paper
• Optical probing of acetylcholine receptors on neurons in the medial habenula with a novel caged nicotine drug analogue

  2018cites this paper
• Computer-aided Drug Design Applied to Parkinson Targets

  2017cites this paper
• Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A.

  2014cites this paper
• Design and synthesis of new agents for neuronal nicotinic acetylcholine receptor (nAChRs) imaging.

  2013cites this paper
• Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists.

  2010cites this paper
• New Alkaloids from Oryza sativa cv. Heugjinjubyeo Bran

  2009cites this paper
• Potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.

  2008cites this paper
• Pharmaceuticals: Natural Products and Natural Product Models

  2008cites this paper
• Novel syntheses of azetidines and azetidinones.

  2008cites this paper
• [18F]fluoropyridines: From conventional radiotracers to the labeling of macromolecules such as proteins and oligonucleotides.

  2007cites this paper
• 2.16 – Bioisosterism

  2007cites this paper
• QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.

  2007cites this paper
• Synthesis of azabicyclo[2.2.n]alkane systems as analogues of 3-[1-methyl-2-(S)-pyrrolidinyl- methoxy]pyridine (A-84543).

  2007cites this paper
• Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.

  2007cites this paper
• QSAR study of a large set of 3-pyridyl ethers as ligands of the α4β2 nicotinic acetylcholine receptor

  2007cites this paper
• Biotransformation of substituted pyridines with dioxygenase-containing microorganisms.

  2006cites this paper
• Nicotinic Agonists, Antagonists, and Modulators From Natural Sources

  2005influential citation
• Pharmacological and Toxicological Evaluation of 2-Fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a Ligand for Imaging Cerebral Nicotinic Acetylcholine Receptors with Positron Emission Tomography

  2005cites this paper
• Acute effects of physostigmine and galantamine on the binding of [18F]fluoro‐A‐85380: A PET study in monkeys

  2005cites this paper
• Fluorine-18-labelled fluoropyridines: advances in radiopharmaceutical design.

  2005cites this paper
• Practical asymmetric synthesis of a non-peptidic alphavbeta3 antagonist.

  2005cites this paper
• Studies on synthesis and evaluation of quantitative structure-activity relationship of 5-[(3'-chloro-4',4'-disubstituted-2-oxoazetidinyl)(N-nitro)amino]-6-hydroxy-3-alkyl/aryl[1,3]azaphospholo[1,5-a]pyridin-1-yl-phosphorus dichlorides.

  2005cites this paper
• 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects

  2004cites this paper
• Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity.

  2004cites this paper
• Novel Nicotinic Acetylcholine Receptor Ligands based on Cytisine, Ferruginine, Anatoxin-a and Choline: In vitro Evaluation and Structure-Activity Relationships

  2004cites this paper
• Imaging Agent for PET Investigations of Brain Nicotinic Acetylcholine Receptors

  2004influential citation
• Evaluation of 5-11C-Methyl-A-85380 as an Imaging Agent for PET Investigations of Brain Nicotinic Acetylcholine Receptors

  2004influential citation
• Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.

  2004cites this paper
• Synthesis of novel aza analogues of 2-substituted-2,3-dihydro-1,4-benzodioxins as potential new scaffolds for drug discovery

  2003cites this paper
• Neuronal nicotinic acetylcholine receptor agonists: pharmacophores, evolutionary QSAR and 3D-QSAR models.

  2003cites this paper
• Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes.

  2003cites this paper
• Radiosynthese und Tierexperimente mit einem neuen nikotinischen Acetylcholin-Rezeptor-Liganden

  2003cites this paper
• Nicotinic acetylcholine receptor agonists: a potential new class of analgesics.

  2003cites this paper
• Neuronal nicotinic acetylcholine receptor ligands as potential analgesics

  2003cites this paper
• Fluoro-A-85380 demonstrated no mutagenic properties in in vivo rat micronucleus and Ames tests.

  2002cites this paper
• Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models.

  2002cites this paper
• Synthesis of 3-[(2S)-azetidin-2-ylmethoxy]-5-[11C]-methylpyridine, an analogue of A-85380, via a Stille coupling

  2002cites this paper
• Long‐lasting occupancy of central nicotinic acetylcholine receptors after smoking: a PET study in monkeys

  2002cites this paper
• The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

  2001cites this paper
• [125/123I] 5-Iodo-3-pyridyl ethers. syntheses and binding to neuronal nicotinic acetylcholine receptors.

  2001cites this paper
• Discovery of ABT-594 and related neuronal nicotinic acetylcholine receptor modulators as analgesic agents

  2000cites this paper
• Synthesis of 3- and 5-endo-(6-Chloro-3-pyridoxy)-methyl-2-azabicyclo[2.2.0]hexane and 3-endo-(6-Chloro-3-pyridoxy)-methyl-2-azabicyclo[2.2.0]hex-5-ene. ABT-594 Analogs

  2000cites this paper
• Development of ligands for in vivo imaging of cerebral nicotinic receptors.

  2000cites this paper
• The pharmacological basis of contemporary pain management.

  2000cites this paper
• Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor.

  2000cites this paper
• A new look at the neuronal nicotinic acetylcholine receptor pharmacophore.

  2000cites this paper
• A new nicotinic acetylcholine minireceptor model: a theoretical thermodynamic analysis of simultaneous cation-π and hydrogen bond interactions

  2000cites this paper
• Cognition enhancement strategies by ion channel modulation of neurotransmission.

  1999cites this paper
• Structure—Activity Studies Related to ABT‐594, a Potent Nonopioid Analgesic Agent: Effect of Pyridine and Azetidine Ring Substitutions on Nicotinic Acetylcholine Receptor Binding Affinity and Analgesic Activity in Mice.

  1999cites this paper
• The analgesic potential of compounds acting at acetylcholine receptors.

  1999cites this paper
• 2-(1-AZETIDINYL)- AND 2-(1-PYRROLIDINYL)PYRIDINE via SNAr REACTIONS OF 2-FLUOROPYRIDINE AND 2-PYRIDINYL TRIFLATE

  1999cites this paper
• Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.

  1999cites this paper
• Composes ether et thioether heterocycliques utilises dans la regulation de la transmission synaptique chimique

  1998cites this paper